Alto Neuroscience (ANRO) Share-based Compensation (2023 - 2026)

Alto Neuroscience has disclosed Share-based Compensation across 4 years of filings, most recently posting $2.8 million for Q1 2026.

• Share-based Compensation for Q1 2026 came in at $2.8 million, up 43.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.0 million (up 20.81% YoY), and the FY2025 annual result was $8.1 million, up 6.25% from the prior year.
• Share-based Compensation came in at $2.8 million for Q1 2026 at Alto Neuroscience, up from $1.9 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $2.8 million in Q1 2026 to a low of $484000.0 in Q1 2023.
• The 4-year median for Share-based Compensation is $1.9 million (2025), against an average of $1.7 million.
• Across the five-year window, Share-based Compensation surged 350.21% in 2024 and retreated 9.68% in 2025, its largest moves.
• Alto Neuroscience's Share-based Compensation stood at $606000.0 in 2023, then jumped by 158.42% to $1.6 million in 2024, then gained by 24.27% to $1.9 million in 2025, then jumped by 45.12% to $2.8 million in 2026.
• The last three Share-based Compensation figures came in at $2.8 million (Q1 2026), $1.9 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.